You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Glaxosmithkline Pharmaceuticals Ltd"

Glaxosmithkline Pharmaceuticals Ltd Closure of Trading Window

  • 27/03/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 13/03/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 04/03/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 03/03/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 03/03/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 28/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 26/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 14/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 13/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 12/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 06/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 06/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 06/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 05/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 04/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 04/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 03/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ende

  • 03/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ende

  • 03/02/2020
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 30/01/2020
  • |
  • bse